Aslan Fred sold ARTV
December 12, 2025 · Form 4 insider transaction
Aslan Fred sold 100,577 shares of Artiva Biotherapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
100,577
Price
N/A
Total value
N/A
InsiderAslan Fred
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateDecember 12, 2025
Filing dateDecember 12, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I.; 25% of the shares vested on February 22, 2022, and the remaining shares vest in 36 equal monthly installments thereafter.